Press release
Peptide Based Hematological Disorders Therapeutics Market Shares, Strategies and Forecast Worldwide, 2018 to 2028
Peptide Based Hematological Disorders Therapeutics
North America Market Set to Dominate the Global Peptide Based Hematological Disorders Therapeutics Market in Terms of Revenue
The market in North America is set to dominate the global peptide based hematological disorders therapeutics market in terms of value and this trend is projected to sustain itself throughout the assessment period. North America peptide based hematological disorders therapeutics market is the most attractive market, growing at a robust CAGR over the assessment period.
Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=189
Icatibant Segment Poised to Touch a Value of Nearly US$ 410 Mn in 2022
As per the forecast of Fact.MR, the icatibant segment is expected to reach a value of nearly US$ 410 Mn in the year 2022. This represents a robust CAGR during the forecast period of 2017-2022. Icatibant segment is expected to account for more than three-fourth of the revenue share of the drug segment by the year 2017 and is expected to lose market share by the end of the year 2022.
Hospital Pharmacies Segment to exhibit a CAGR of 7.4% During the Assessment Period
As per the forecast of Fact.MR, the hospital pharmacies segment is slated to touch a figure of nearly US$ 260 Mn in the year 2022. This represents a CAGR of 7.4% during the assessment period from 2017 till the year 2022. This segment is expected to lose market share by the end of the year 2022. The hospital pharmacies segment is expected to account for more than half of the revenue share of the distribution channel segment by the year 2017.
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global peptide based hematological disorders therapeutics market through 2022, which includes Shire plc.
Due to the advances in technology, the manufacturers and suppliers are encouraged to seek novel methods for peptide manufacturing, which is bound to improve the production of longer and complex chain of peptides and reduce the cost of production. Moreover, due to the automation of instruments, with improvements in the purification process and reduction in the total waste generated, are the driving factors triggering the growth of the global peptide therapeutics market. However, the synthesis and purification of long peptides is challenging for the manufacturers. Also, the rise in modifications and the addition of more unnatural amino acids have further increased the complications in peptide synthesis. This makes the manufactures of peptides difficult, and therefore the gap between demand and supply is increasing. Also, the manufacturing of peptides is a costly process, which hampers the growth of the global peptide therapeutics market.
Request/View Toc@ https://www.factmr.com/connectus/sample?flag=T&rep_id=189
Detailed TOC of Global Peptide Based Hematological Disorders Therapeutics Market by Manufacturers, Regions, Type and Application, Forecast to 2022
1. Global Peptide Based Hematological Disorders Therapeutics Market - Executive Summary
2. Global Peptide Based Hematological Disorders Therapeutics Market Overview
2.1. Introduction
2.1.1. Global Peptide Based Hematological Disorders Therapeutics Market Taxonomy
2.1.2. Global Peptide Based Hematological Disorders Therapeutics Market Definition
2.2. Global Peptide Based Hematological Disorders Therapeutics Market Size (US$ Mn) and Forecast, 2012-2022
2.2.1. Global Peptide Based Hematological Disorders Therapeutics Market Y-o-Y Growth
2.3. Global Peptide Based Hematological Disorders Therapeutics Market Dynamics
2.4. Regulations
2.5. Supply Chain
2.6. Cost Structure
2.7. Average Pricing Analysis
2.8. Epidemiology
2.9. Key Participants Market Presence (Intensity Map) By Region
Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=189
3. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Drug
3.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Drug, 2012-2022
3.1.1. Icatibant Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.1.1. Revenue (US$ Mn) Comparison, By Region
3.1.1.2. Market Share Comparison, By Region
3.1.1.3. Y-o-Y growth Comparison, By Region
3.1.2. Ecallantide Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
3.1.2.1. Revenue (US$ Mn) Comparison, By Region
3.1.2.2. Market Share Comparison, By Region
3.1.2.3. Y-o-Y growth Comparison, By Region
4. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Distribution Channel
4.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast By Distribution Channel, 2012-2022
4.1.1. Hospital Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Retail Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Online Pharmacies Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
Access This Report @ https://www.factmr.com/checkout/189/S
5. Global Peptide Based Hematological Disorders Therapeutics Market Analysis and Forecast By Region
5.1. Global Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1. North America Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.1.1. Revenue (US$ Mn) Comparison, By Drug
5.1.1.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.2. Latin America Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.2.1. Revenue (US$ Mn) Comparison, By Drug
5.1.2.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.3. Europe Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.3.1. Revenue (US$ Mn) Comparison, By Drug
5.1.3.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.4. Japan Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.4.1. Revenue (US$ Mn) Comparison, By Drug
5.1.4.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.5. APEJ Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.5.1. Revenue (US$ Mn) Comparison, By Drug
5.1.5.2. Revenue (US$ Mn) Comparison, By Distribution Channel
5.1.6. MEA Peptide Based Hematological Disorders Therapeutics Market Size and Forecast, 2012-2022
5.1.6.1. Revenue (US$ Mn) Comparison, By Drug
5.1.6.2. Revenue (US$ Mn) Comparison, By Distribution Channel
And Continue...
List of Figures, Tables and Charts Available in Global Peptide Based Hematological Disorders Therapeutics Market 2017 by Manufacturers, Regions, Type and Application, Forecast to 2022
TABLE 1 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2012-2016
TABLE 2 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2017-2022
TABLE 3 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
TABLE 4 Global Icatibant Segment Value (US$ Mn), By Region 2012-2016
TABLE 5 Global Icatibant Segment Value (US$ Mn), By Region 2017-2022
TABLE 6 Global Icatibant Segment Market Share, By Region 2012-2016
TABLE 7 Global Icatibant Segment Market Share, By Region 2017-2022
TABLE 8 Global Icatibant Segment Y-o-Y, By Region 2015-2022
TABLE 9 Global Ecallantide Segment Value (US$ Mn), By Region 2012-2016
TABLE 10 Global Ecallantide Segment Value (US$ Mn), By Region 2017-2022
TABLE 11 Global Ecallantide Segment Market Share, By Region 2012-2016
TABLE 12 Global Ecallantide Segment Market Share, By Region 2017-2022
TABLE 13 Global Ecallantide Segment Y-o-Y, By Region 2015-2022
TABLE 14 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2012-2016
TABLE 15 Global Hospital Pharmacies Segment Value (US$ Mn), By Region 2017-2022
And Continue...
FIG. 1 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn), 2012-2016
FIG. 2 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) Forecast, 2017-2022
FIG. 3 Global Peptide Based Hematological Disorders Therapeutics Market Value (US$ Mn) and Y-o-Y, 2015-2022
FIG. 4 Global Icatibant Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 5 Global Icatibant Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 6 Global Icatibant Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 7 Global Ecallantide Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 8 Global Ecallantide Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 9 Global Ecallantide Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 10 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 11 Global Hospital Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 12 Global Hospital Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
FIG. 13 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2016
FIG. 14 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2017-2022
FIG. 15 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2015-2022
And Continue...
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/
Follow Us on Linkedin: www.linkedin.com/company/factmr/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Peptide Based Hematological Disorders Therapeutics Market Shares, Strategies and Forecast Worldwide, 2018 to 2028 here
News-ID: 1595444 • Views: …
More Releases from Fact.MR
Citrus Peel Fibre and Pectin Market Projected to Reach USD 1.91 Billion by 2035, …
The global citrus peel fibre and pectin market is set to experience substantial growth over the next decade, driven by rising consumer demand for natural ingredients, increasing adoption in the food and beverage industry, and the growing focus on health and wellness.
According to recent analysis, the market is projected to grow from USD 1,100.0 million in 2025 to approximately USD 1,914.9 million by 2035, marking a total growth of…
Brewers' Spent Grain Flour Market to Hit USD 651M by 2035, Driven by Sustainabil …
The global brewers' spent grain flour market is projected to grow from USD 385.0 million in 2025 to approximately USD 651.4 million by 2035, recording an absolute increase of USD 267.7 million over the forecast period.
This translates into a total growth of 69.5%, with the market forecast to expand at a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. The rising focus on upcycling brewery byproducts…
Global Hybrid Emulsifiers Market to Surpass USD 1 Billion by 2035, Driven by Cle …
The global hybrid emulsifiers market is witnessing strong growth and is projected to reach USD 1,013.2 million by 2035, up from USD 550 million in 2025.
With a compound annual growth rate (CAGR) of 6.3% over the forecast period, the industry is being fueled by increasing demand for natural, multifunctional emulsifiers across food, beverage, and personal care sectors. The market is experiencing a shift towards clean-label and sustainable ingredients, reflecting…
Chlorella-Derived Whole-Food Colours Market to Reach USD 171.7 Million by 2035, …
The global chlorella-derived whole-food colours market is experiencing robust growth, driven by rising consumer demand for natural and clean-label ingredients.
The market is projected to expand from USD 95.0 million in 2025 to approximately USD 171.7 million by 2035, reflecting a total increase of USD 80.0 million and a compound annual growth rate (CAGR) of 6.1%. This growth trajectory highlights the increasing adoption of chlorella-based colourants in the food, beverage,…
More Releases for Region
Lactase Market Leaders, Region, Product & Application
Persistence Market Research (PMR) has published a research report titled "Lactase Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025." The report states that the global market for lactase is expected to be impacted by the growing application of lactase enzyme and its various benefits. The increasing awareness among people is further expected to bode well for the growth of the market in the coming years. According to PMR, the global…
Medical Marijuana Market - (region Name) Is The Leading Region In The Global Ind …
Zion Market Research Offers an 8-Year Forecast In 110+ Pages Research Report Titled "Medical Marijuana Market by Product (Dried Form and Extract Form), by Application (Pain Management, Seizure, and Others), and by Distribution Channel (Retail Pharmacy and E-Commerce): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2017 - 2024" Between Forecasting Years. The main objective of this Male Infertility Treatment Market report is to offer update and information on the market…
Mountain Bike Market - Europe Region Shows Highest Market Share followed by the …
Global Mountain Bike Market: Overview
A mountain bicycle, commonly referred to as mountain bike, is meant for off-road cycling. It exhibits greater durability and performance in choppy terrains and is typically ridden on mountainous regions which have hard rocks, loose dirt, muddy or grassy tracks, and steep slopes. The sales of mountain bikes have steadily risen over the course of years with new players entering it with new and better products.
Get…
Pajamas Market 2025 | Market Forecast by Product, Application & Region, Cost Str …
Pajamas Market Overview
Reports Monitor has deployed a patented Pajamas Market. research methodology that is the complete concoction of meticulous primary and secondary research together with the entrust of the industry specialists. The research study and number crunching then persist a multi-layer authentication process to clean up all the required quantitative and qualitative insights that could profit business by directly striking the long-term decisions. This research methodology has been applied to examine the Pajamas market…
US Men’s Underwear Market 2026 |Industry Key Regions : Northeast, West region, …
As the large amount of data is being generated everyday by companies all over the world, a new research study titled “Men’s Underwear Market: Increasing Number of Metrosexual Men in the U.S. Anticipated to Fuel Revenue Growth of the Boxer Shorts Segment During the Forecast Period: U.S. Industry Analysis and Opportunity Assessment, 2016-2026” has been generated and recently added into the vast database of Market Research Reports Search Engine (MRRSE).…
Data Center Construction Market In Nordic Region Shows Rapid Growth Through Incr …
MarketResearchReports.biz hosts a collection of high-demand market intelligence reports on multiple sectors, including within the global ICT industry. One of the latest research reports to be added in this repertoire is “Data Center Construction Market In Nordics 2016-2020,” which is an 82 paged document that addresses the key factors that are responsible for the growth of this market.
The Nordic region is experiencing a rapid rate of growth in the fields…
